Envista Holdings Co. (NYSE:NVST) Shares Bought by Royce & Associates LP

Royce & Associates LP boosted its holdings in shares of Envista Holdings Co. (NYSE:NVSTFree Report) by 6.3% in the 3rd quarter, Holdings Channel reports. The firm owned 278,904 shares of the company’s stock after buying an additional 16,547 shares during the period. Royce & Associates LP’s holdings in Envista were worth $5,511,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in NVST. Ariel Investments LLC lifted its stake in Envista by 11.0% during the second quarter. Ariel Investments LLC now owns 9,871,152 shares of the company’s stock valued at $164,157,000 after buying an additional 978,952 shares in the last quarter. Nuance Investments LLC raised its stake in Envista by 47.2% during the 2nd quarter. Nuance Investments LLC now owns 7,038,313 shares of the company’s stock valued at $117,048,000 after purchasing an additional 2,256,993 shares during the period. American Century Companies Inc. lifted its holdings in shares of Envista by 15.4% in the second quarter. American Century Companies Inc. now owns 6,726,651 shares of the company’s stock valued at $111,864,000 after purchasing an additional 897,141 shares in the last quarter. Jupiter Asset Management Ltd. acquired a new stake in shares of Envista in the second quarter worth $69,534,000. Finally, Van Lanschot Kempen Investment Management N.V. grew its holdings in shares of Envista by 32.9% during the second quarter. Van Lanschot Kempen Investment Management N.V. now owns 2,936,916 shares of the company’s stock valued at $48,841,000 after buying an additional 727,406 shares in the last quarter.

Envista Price Performance

Shares of NYSE:NVST opened at $20.61 on Tuesday. The stock has a market capitalization of $3.55 billion, a P/E ratio of -2.65, a P/E/G ratio of 2.86 and a beta of 1.30. The business has a 50-day moving average of $19.27 and a two-hundred day moving average of $18.11. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $25.64. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77.

Envista (NYSE:NVSTGet Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm had revenue of $601.00 million during the quarter, compared to analyst estimates of $590.34 million. During the same period in the previous year, the company earned $0.43 EPS. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. On average, equities research analysts predict that Envista Holdings Co. will post 0.72 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on NVST shares. Robert W. Baird raised their price objective on Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Stifel Nicolaus raised their price target on shares of Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. JPMorgan Chase & Co. lowered shares of Envista from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $23.00 to $16.00 in a research note on Thursday, August 8th. Evercore ISI lifted their target price on shares of Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Finally, Wells Fargo & Company began coverage on shares of Envista in a research note on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 price target on the stock. One analyst has rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $20.71.

Read Our Latest Report on NVST

Envista Company Profile

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Further Reading

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVSTFree Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.